The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the ...
A recent study suggests people may have protection from the coronavirus for years if they received the Pfizer-BioNTech or Moderna vaccine. The study was published in the journal Nature. “Overall, our ...
Pfizer says it is about to seek U.S. authorization for a third dose of its COVID-19 vaccine. The company said Thursday that another shot could dramatically boost immunity and maybe help ward off the ...